Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series

<i>p53</i> Status and the Efficacy of Cancer Therapy in Vivo

Scott W. Lowe, Stephan Bodis, Andrea I. McClatchey et al. · Science · 1994 · 1.5K citations

Cancer Therapy, P53 Status, Apoptosis +17

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

Eric Wattel, Claude Preudhomme, B Hecquet et al. · Blood · 1994 · 580 citations · Full text

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.

Sabina Carla Righetti, Gabriella Della Torre, S. Pilotti et al. · PubMed · 1996 · 281 citations

Medicine, P53 Gene Mutations, Pathology +14

Placental S100 (S100P) and GATA3: Markers for Transitional Epithelium and Urothelial Carcinoma Discovered by Complementary DNA Microarray

Julian P. T. Higgins, Gülşah Kaygusuz, Lingli Wang et al. · The American Journal of Surgical Pathology · 2007 · 229 citations

Tumor Biology, Urology, Complementary Dna Microarray +13

<i>TP53</i> Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma

Federica Perrone, Paolo Bossi, Barbara Cortelazzi et al. · Journal of Clinical Oncology · 2010 · 149 citations · Full text

Tumor Biology, Surgical Oncology, Pathologic Complete Response +15